Sign In
Buy CL
$84.87
-3.40 (-3.85%)
At Close: Jun 03, 2026
Here's How Colgate is Poised Post Q1 Earnings: Buy or Hold the Stock?
01:10pm, Wednesday, 30'th Apr 2025
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Best Dividend Aristocrats For May 2025
08:07pm, Tuesday, 29'th Apr 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed
Colgate-Palmolive Webcasts Fireside Chat at the Goldman Sachs Global Staples Forum
10:15am, Tuesday, 29'th Apr 2025
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) President, Hill's Pet Nutrition, John Hazlin, and Chief Investor Relations Officer and EVP, M&A, John Faucher, will participate in a fireside cha
Colgate-Palmolive Analysts Increase Their Forecasts After Upbeat Results
12:58pm, Monday, 28'th Apr 2025
Colgate-Palmolive Co CL posted better-than-expected first-quarter FY25 earnings on Friday.
Which Dividend King Is the Better Dividend Stock: Colgate-Palmolive (CL) or Emerson Electric (EMR)
11:50am, Monday, 28'th Apr 2025
Colgate-Palmolive and Emerson Electric are both financially solid businesses to invest in.
Colgate-Palmolive Webcasts 2025 Annual Meeting of Stockholders May 9, 2025 – 10:00 a.m. ET
09:30am, Monday, 28'th Apr 2025
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live video webcast of its 2025 Annual Meeting of Stockholders on Friday, May 9, 2025 at 10:00 a.m. ET. Investors may acces
Colgate Q1 Earnings & Sales Beat Estimates, Organic Sales Rise 1.4%
01:40pm, Friday, 25'th Apr 2025
CL posts better-than-expected first-quarter 2025 results. Results benefited from organic sales growth, robust volume and pricing performance.
Colgate-Palmolive Q1: Earnings Remain Stable Despite Global Uncertainty
01:32pm, Friday, 25'th Apr 2025
Colgate-Palmolive Company reported Q1 results, showing relatively stable underlying sales. The consumer environment remains cautious, causing pressure in some markets and a more cautious underlying ou
Colgate-Palmolive Company (CL) Q1 2025 Earnings Call Transcript
11:51am, Friday, 25'th Apr 2025
Colgate-Palmolive Company (NYSE:CL ) Q1 2025 Earnings Conference Call April 25, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer & Executive Vice President, M&A Noe
Colgate-Palmolive (CL) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Friday, 25'th Apr 2025
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall
Colgate: EPS Beats Estimates, Sales Dip
10:18am, Friday, 25'th Apr 2025
Colgate-Palmolive (CL 0.36%), a leading manufacturer of consumer products in Oral Care, Personal Care, Home Care, and Pet Nutrition, posted its Q1 2025 earnings on April 25, 2025. However, its GAAP re
Colgate-Palmolive cuts full-year outlook despite earnings beat, citing tariff pressures
09:38am, Friday, 25'th Apr 2025
Colgate-Palmolive Co (NYSE:CL) has cut its full-year earnings outlook, citing the impact of tariffs and currency headwinds, even as it posted first-quarter earnings that topped Wall Street expectation
Colgate-Palmolive (CL) Tops Q1 Earnings and Revenue Estimates
09:06am, Friday, 25'th Apr 2025
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.86 per share a year ago.
Colgate-Palmolive's quarterly results beat, raises annual sales forecast
08:39am, Friday, 25'th Apr 2025
Colgate-Palmolive reported quarterly results that beat Wall Street estimates and raised its annual sales forecast on Friday, banking on moderate price hikes and higher advertising spending to boost de
Colgate-Palmolive Tops Q1 Estimates, Lifts Full-Year Net Sales Outlook
08:35am, Friday, 25'th Apr 2025
Colgate-Palmolive (CL) on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, although it lowered its profit projection.
